IFNG increases tumour cell immunogenicity, by upregulating components of the major histocompatibility complex (MHC) class I protein and promotes maturation of dendritic cells (DCs), generation of Th1 cells and CTLs and activates cytocidal activity in macrophages. This evidence concerns the gene IFNG and neoplasm.